Markt für Laborautomatisierung in der Bioanalyse – Wachstum, Trends, Auswirkungen von COVID-19 und Prognosen (2022 – 2027)

Der Markt für Laborautomatisierung in der Bioanalyse ist nach Angebot (Ausrüstung, Software), Analysatoren (Biochemie-Analysatoren, immunbasierte Analysatoren, Hämatologie-Analysatoren, Zellzähler, Koagulometer) und Geografie unterteilt.

Market Snapshot

lab automation in bioanalysis market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: North America
Largest Market: Asia Pacific
CAGR: 5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The lab automation in bioanalysis market was valued at USD 5.06 billion in 2020 and is expected to reach USD 7.10 billion by 2026, at a CAGR of 5.8% over the forecast period (2021 - 2026). Lab automation is required in bioanalysis applications, as manual and traditional handling can result in a corrupted or infected sample. The emergence of automated solutions, such as automated liquid handlers, automated plate handlers, and robotics, has eliminated the need for human intervention in bioanalysis laboratories by increasing accuracy and improving efficiency.

  • For clinical trials, it is sometimes imperative to monitor drug levels in subjects in real-time, which enables medical monitors and clinical investigators to adjust the dosing to meet the subject's needs and study requirements. Thus, clinical trials and diagnostics require bioanalysis technologies. Automated handling makes it easier to obtain error-free results. Owing to the rise in the number of clinical trials and studies and the growth in complexity, lab automation in bioanalysis is projected to experience significant demand.
  • Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and the large gap in workforce demand and supply, have driven the growth of the market across the world. Moreover, factors, such as technological innovations leading to device miniaturization and increased throughput and rising demand for personalized medicines, are significantly driving the market growth.
  • However, high capital requirements for setup will be a major hindrance to market growth.

Scope of the Report

Lab automation in bioanalysis involves the use of dedicated work-stations and software to program instruments to automate routine laboratory procedures. The extent of automation required is dependent on the nature of the task to be performed, the need for processing, and the amount of human intervention.

By Offering
Equipment
Automated Liquid Handlers
Automated Plate Handlers
Robotic Arms
AS/RS
Vision Systems
Software
By Analyzers
Biochemistry Analyzers
Immuno-Based Analyzers
Hematology Analyzers
Cell Counters
Coagulometers
Geography
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Report scope can be customized per your requirements. Click here.

Key Market Trends

Robotic Arms to be the Fastest Growing Equipment Segment

  • Robotic arms in lab automation are used for chemical analysis. Pharmaceutical companies are employing robots to move samples around the workspace for diagnosing chemical entities from the existing sample. Robotic arms are used for sample handling, coupled with new technologies, to eliminate errors.
  • The pharmaceutical industry has experienced increased use of robotic arms, as the synthesizing of samples with structural analysis can be done automatically. Robotic arms are used in applications, like biological and combinatorial chemistry for sample diagnosis, with automation increasing the market’s standards.
  • Further, robotic arms also help in doing the mundane task in the laboratory set up saving time and energy of a human being doing that task. According to IFR, World Robotics 2018, sales of medical robots increased by 73% compared in 2016 to 2,931 units in 2017, accounting for a share of 2.7% of the total unit sales of professional service robots. The major reason identified for an increased sale has been the wide use in robotic surgery and laboratory automation in clinics.
lab automation in bioanalysis market

Nordamerika hält den größten Marktanteil

  • Eine Zunahme der Anzahl globaler klinischer und vorklinischer Studien hat die Notwendigkeit einer schnellen Analyse von Proben zwingend erforderlich gemacht, wodurch die Automatisierung zu einer der Schlüsselkomponenten wird, die zum Wachstum des Marktes beitragen.
  • Verschiedene Aspekte, wie z. B. zunehmende Reproduzierbarkeit und Genauigkeit, Miniaturisierung des Prozesses, fortschreitende Arzneimittelforschung, klinische Diagnostik und die große Lücke bei Bedarf und Angebot an Arbeitskräften, haben das Wachstum des Marktes auf der ganzen Welt vorangetrieben. Wirtschaftlichkeit durch Routinearbeiten, professionelle Arbeitskosten und präzises Handling ist eine Variable, die die Nachfrage nach diesen Lösungen beeinflusst.
  • Strenge Vorschriften der US-Regierung und der FDA, die wachsende Nachfrage auf dem Diagnostikmarkt und die zunehmende Nutzung von Entdeckungs- und Forschungslabors aufgrund der zunehmenden Präsenz verschiedener Krankheiten wie Herz-Kreislauf-Erkrankungen und neurologischer Erkrankungen in der Region haben dazu beigetragen das Wachstum des Marktes. Die USA dominieren den nordamerikanischen Markt und leisten den größten Umsatzbeitrag in der Region.
lab automation in bioanalysis market

Competitive Landscape

Der Markt für Laborautomatisierung in der Bioanalyse wird konsolidiert. Hauptakteure haben den maximalen Marktanteil. Außerdem konkurrieren die Akteure auf dem Markt für Laborautomatisierung in der Bioanalyse zunehmend aufgrund von Faktoren wie Produktinnovationen und technologischen Fortschritten. Einige der Hauptakteure sind Thermo Fisher Scientific, Beckman Coulter (Danaher Corporation), Hudson Robotics, Becton Dickinson, Synchron Lab Automation, Agilent Technologies, Siemens Healthcare, Tecan Group Ltd, PerkinElmer, Bio-Rad, Roche Holding AG, Eppendorf AG, Shimadzu und Aurora Biomed, unter anderem.

  • Mai 2019 – Beckman Coulter kündigt die neueste Ergänzung seines Automatisierungsportfolios an. Die vollständige Laborautomatisierungslösung DxA 5000 hat die europäische CE-Kennzeichnung und die Zulassung der chinesischen Lebensmittel- und Arzneimittelbehörde erhalten. Im Gesundheitswesen konzentrieren sich Labore stark auf die Verbesserung der Patientenversorgung, indem sie schnellere Durchlaufzeiten erzielen, qualitativ hochwertige Ergebnisse liefern und den Laborbetrieb verbessern. Das DxA 5000 hilft Labors, diese Herausforderungen durch eine Sammlung patentierter Innovationen zu meistern, die eine schnelle und konsistente Bearbeitungszeit bieten, ein neues Niveau der umfassenden präanalytischen Probenqualitätserkennung bieten und die Anzahl manueller Verarbeitungsschritte reduzieren, um die Laboreffizienz erheblich zu verbessern. 
  • September 2018 – Tecan hat die Übernahme von NuGEN Technologies erfolgreich abgeschlossen.

Hauptakteure

  1. Thermo Fisher Scientific

  2. Becton Dickinson

  3. Siemens Healthcare

  4. Beckman Coulter (Danaher Corporation)

  5. Roche-Holding AG

lab automation in bioanalysis market

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Demand for Personalized Medicines

      2. 4.2.2 Technological Innovations Resulting in Improved Solutions

    3. 4.3 Market Restraints

      1. 4.3.1 High Capital Requirements for Setup

    4. 4.4 Industry Value Chain Analysis

    5. 4.5 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.5.1 Bargaining Power of Suppliers

      2. 4.5.2 Bargaining Power of Buyers/Consumers

      3. 4.5.3 Threat of New Entrants

      4. 4.5.4 Threat of Substitute Products

      5. 4.5.5 Intensity of Competitive Rivalry

    6. 4.6 Technology Snapshot

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Offering

      1. 5.1.1 Equipment

        1. 5.1.1.1 Automated Liquid Handlers

        2. 5.1.1.2 Automated Plate Handlers

        3. 5.1.1.3 Robotic Arms

        4. 5.1.1.4 AS/RS

        5. 5.1.1.5 Vision Systems

      2. 5.1.2 Software

    2. 5.2 By Analyzers

      1. 5.2.1 Biochemistry Analyzers

      2. 5.2.2 Immuno-Based Analyzers

      3. 5.2.3 Hematology Analyzers

      4. 5.2.4 Cell Counters

      5. 5.2.5 Coagulometers

    3. 5.3 Geography

      1. 5.3.1 North America

      2. 5.3.2 Europe

      3. 5.3.3 Asia-Pacific

      4. 5.3.4 Latin America

      5. 5.3.5 Middle East & Africa

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific Inc.

      2. 6.1.2 Agilent Technologies

      3. 6.1.3 Beckman Coulter Inc. (Danaher Corporation)

      4. 6.1.4 Hamilton Company

      5. 6.1.5 Hudson Robotics Inc.

      6. 6.1.6 Becton, Dickinson and Company

      7. 6.1.7 Siemens Healthineers AG

      8. 6.1.8 Tecan Group Ltd

      9. 6.1.9 Shimadzu Corporation

    2. *List Not Exhaustive
  7. 7. INVESTMENT ANALYSIS

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Lab Automation in Bioanalysis Market market is studied from 2018 - 2026.

The Lab Automation in Bioanalysis Market is growing at a CAGR of 5.8% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

Asia Pacific holds highest share in 2021.

Thermo Fisher Scientific, Becton Dickinson, Siemens Healthcare, Beckman Coulter (Danaher Corporation ), Roche Holding AG are the major companies operating in Lab Automation in Bioanalysis Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!